Food News and Research

RSS

DARPA grants $5.6 million to Dana-Farber to develop viable countermeasures against unknown pathogen

Researchers at Dana-Farber Cancer Institute have received a $5.6 million grant from the Defense Advanced Research Projects Agency and the Army Research Office to develop transient immunity against known, unknown, naturally occurring, or engineered disease-causing pathogens.

20 Jan 2011

FDA unveils plan to improve marketing and review process for medical devices

The U.S. Food and Drug Administration today unveiled a plan containing 25 actions it intends to implement during 2011 to improve the most common path to market for medical devices.

20 Jan 2011

Prevention launches free content area on diabetes

Today, Prevention—the #1 healthy lifestyle brand in the world—launches Outsmart Diabetes: a personalized, feature-rich, free content area consisting of all Prevention's superior diabetes coverage at http://www.diabetes.prevention.com. Outsmart Diabetes joins Prevention's overall diabetes platform, which includes books, DVD's, special interest publications and bookazines.

20 Jan 2011

Oral contraceptives do not cause weight gain, says new study

According to research conducted at the Oregon National Primate Research Center at Oregon Health & Science University, the commonly held belief that oral contraceptives cause weight gain appears to be false. The results of the study are published online and will appear in next month's edition of the journal Human Reproduction.

20 Jan 2011

Apricus Bio's MycoVa demonstrates 'non-inferiority' for treatment of onychomycosis compared to Loceryl

Apricus Biosciences, Inc. today announced that an additional analysis conducted on behalf of the Company has shown that MycoVa™ has successfully demonstrated 'non-inferiority' for the treatment of onychomycosis (commonly referred to as nail fungus), compared to the current standard of care in Europe for topical therapy, Loceryl®.

20 Jan 2011

FDA establishes PDUFA date for ADVENTRX's Exelbine NDA review

ADVENTRX Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has established a Prescription Drug User Fee Act (PDUFA) date of September 1, 2011 for the review of the Exelbine (ANX-530) New Drug Application (NDA).

20 Jan 2011

Boston Scientific announces merger agreement to acquire Atritech

Boston Scientific Corporation today announced the signing of a definitive merger agreement, under which the Company will acquire Atritech, a privately held company based in Plymouth, Minnesota.

19 Jan 2011

Pluristem completes parallel scientific advisory process with EMA and FDA for PLX-PAD clinical development

Pluristem Therapeutics, Inc. today announced the successful completion of a parallel scientific advisory process with the European Medical Agencies (EMA) and the U.S. Food and Drug Administration (FDA) regarding the Company's planned clinical development program for PLX-PAD.

19 Jan 2011

Tips to maintain healthy lifestyle

The start of the New Year often brings great intentions and an ambitious list of resolutions — some attainable and most? Completely unsustainable. For many, personal resolutions to achieving better health, such as weight loss or quitting smoking, wane quickly along with the initial good objectives and keen enthusiasm.

19 Jan 2011

Dextran-coated onto iron oxide nanoparticles can detect cholera toxin: Study

A complex sugar may someday become one of the most effective weapons to stop the spread of cholera, a disease that has claimed thousands of lives in Haiti since the devastating earthquake last year.

19 Jan 2011

Study shows risky knowledge gaps, deficits in dietary supplements among pregnant women

Research conducted by the Chair of Nutritional Medicine at the Technische Universitaet Muenchen indicates there are knowledge gaps: According to this study, pregnant women often start taking sensible dietary supplements too late or not at all. At the same time, other micronutrients are unwittingly overdosed whose effects during pregnancy have not yet been studied.

19 Jan 2011

MD Anderson experts create plan to guide women on healthy behaviors

"A woman's life changes at every decade and so does her body," says Therese Bevers, M.D., medical director of MD Anderson's Cancer Prevention Center. "And, just as a woman sets personal and work-related milestones, she also should set health goals for every stage of life."

19 Jan 2011

American Heart Association documents commitment to improve heart and stroke-related public policy

The American Heart Association has, for the first time, published a statement, "American Heart Association and Nonprofit Advocacy: Past, Present, and Future," that documents the association's longstanding commitment to improve heart and stroke-related public policy.

19 Jan 2011

Ridaforolimus achieves primary endpoint in Phase 3 trial for metastatic soft-tissue and bone sarcomas

ARIAD Pharmaceuticals, Inc., today announced top-line data showing that ridaforolimus, an investigational oral mTOR inhibitor, met the primary endpoint of improved progression-free survival (PFS) compared to placebo in the Phase 3 SUCCEED trial conducted in patients with metastatic soft-tissue or bone sarcomas who previously had a favorable response to chemotherapy.

19 Jan 2011

Loyola offers new, nonsurgical treatment for Dupuytren's contracture

Loyola University Health System is among the first centers to offer a new, nonsurgical treatment for Dupuytren's contracture, a debilitating condition that curls fingers toward the palm.

19 Jan 2011

Deep brain stimulation stabilizes motor symptoms in Parkinson's disease over time

Parkinson's disease symptoms begin subtly and worsen as damage to certain brain cells continues. But an electrical stimulation device implanted deep in the brain and programmed remotely, along with medications, may provide some control of "motor symptoms" common to the disease, such as shaking, stiffness, and loss of muscle control.

19 Jan 2011

New project on developing countermeasures for natural and intentional exposure to disease pathogens

Researchers at Dana-Farber Cancer Institute have received a $5.6 million grant from the Defense Advanced Research Projects Agency (DARPA) and the Army Research Office (ARO) to develop transient immunity against known, unknown, naturally occurring, or engineered disease-causing pathogens. The ultimate goal is to develop a viable countermeasure to an unknown pathogen within seven days of receiving it in a laboratory.

19 Jan 2011

Cancer cells brought back under normal control

Scientists at The University of Nottingham have brought cancer cells back under normal control — by reactivating their cancer suppressor genes. The discovery could form a powerful new technology platform for the treatment of cancer of the breast and other cancers.

19 Jan 2011

Aastrom secures US patent for autologous cell therapy product

Aastrom Biosciences, a leading developer of expanded autologous cellular therapies for severe, chronic cardiovascular diseases, today announced that it has been granted a U.S. patent which provides composition of matter protection for its investigational expanded autologous cell therapy product.

19 Jan 2011

Antioxidants may cause fertility problems in females

Antioxidants are sold over the counter everywhere. They're added to food, drink and face cream. But according to Prof. Nava Dekel of the Biological Regulation Department, we still don't have a complete understanding of how they act in our bodies. New research by Dekel and her team, recently published in the Proceedings of the National Academy of Sciences USA (PNAS), has revealed a possible unexpected side effect of antioxidants: They might cause fertility problems in females.

19 Jan 2011

Food News and Research

DARPA grants $5.6 million to Dana-Farber to develop viable countermeasures against unknown pathogen

FDA unveils plan to improve marketing and review process for medical devices

Prevention launches free content area on diabetes

Oral contraceptives do not cause weight gain, says new study

Apricus Bio's MycoVa demonstrates 'non-inferiority' for treatment of onychomycosis compared to Loceryl

FDA establishes PDUFA date for ADVENTRX's Exelbine NDA review

Boston Scientific announces merger agreement to acquire Atritech

Pluristem completes parallel scientific advisory process with EMA and FDA for PLX-PAD clinical development

Tips to maintain healthy lifestyle

Dextran-coated onto iron oxide nanoparticles can detect cholera toxin: Study

Study shows risky knowledge gaps, deficits in dietary supplements among pregnant women

MD Anderson experts create plan to guide women on healthy behaviors

American Heart Association documents commitment to improve heart and stroke-related public policy

Ridaforolimus achieves primary endpoint in Phase 3 trial for metastatic soft-tissue and bone sarcomas

Loyola offers new, nonsurgical treatment for Dupuytren's contracture

Deep brain stimulation stabilizes motor symptoms in Parkinson's disease over time

New project on developing countermeasures for natural and intentional exposure to disease pathogens

Cancer cells brought back under normal control

Aastrom secures US patent for autologous cell therapy product

Antioxidants may cause fertility problems in females

Enhancing confidence in chemical ionization spectrometry data eBook

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News